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Background: Urinary tract infection (UTI) complicates sepsis
and/or disseminated intravascular coagulation (DIC) when the dis-
ease becomes severe; mortalities of septic DIC is reported to reach
to 37% despite current therapy. Cross-talk between the coagula-
tion system and inﬂammatory reactions during sepsis causes organ
damage followed by multiple organ dysfunction syndrome or even
death. Therefore, anticoagulant therapies have been expected to be
beneﬁcial in the treatment of severe sepsis. Recombinant human
soluble thrombomodulin (rhTM) binds to thrombin to inactivate
coagulation, and the thrombin-rhTM complex activates protein C
to produce activated protein C. The purpose of this study was to
examine the efﬁcacy of rhTM for treating patients with septic UTI-
induced DIC.
Methods & Materials: This study comprised 45 patients with
septic UTI-induced DIC. All patients fulﬁlled the criteria of severe
sepsis and the International Society on Thrombosis and Haemosta-
sis criteria forovertDIC. The initial 25patientswere treatedwithout
rhTM (control group), and the following 20 consecutive patients
were treatedwith rhTM(0.06mg/kg/day) for sixdays (rhTMgroup).
The primary outcome measure was 28-day mortality. Stepwise
multivariateCox regression analysiswasused to assesswhich inde-
pendent variables were associated with mortality. Comparisons of
Sequential Organ Failure Assessment (SOFA) score on sequential
days between the two groupswere analyzed by repeatedmeasures
analysis of variance.
Results: Cox regression analysis showed 28-day mortality to be
signiﬁcantly lower in the rhTM group than in the control group
(adjusted hazard ratio, 0.301; 95% conﬁdence interval, 0.104 to
0.867; P = 0.028). SOFA score in the rhTM group decreased signiﬁ-
cantly in comparison with that in the control group (P = 0.029). In
the post hoc test, SOFA score decreased rapidly in the rhTM group
compared with that in the control group on day 1 (P < 0.05).
Conclusion: We found that rhTM administration may improve
organ dysfunction in patients with septic UTI-induced DIC. Further
clinical investigations are necessary to evaluate the effect of rhTM
on the pathophysiology of septic UTI-induced DIC.
http://dx.doi.org/10.1016/j.ijid.2014.03.877
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Re-emergence of yellow fever in Kedougou,
Southeastern Senegal in 2010-2011
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Background: Yellow fever (YF) is an acute infectious viral dis-
ease transmitted by Aedesmosquitoes that causes 200,000 human
cases and30,000deaths annually in tropicalAfrica andSouthAmer-
ica. Human cases follow periodic emergence YF virus (YFV) from
its sylvatic cycle in non-human primates. In Senegal, the Kedougou
region is an emergence zone where ampliﬁcations of sylvatic YFV
have been reported at 4 to 6 years interval. Since 2007, gold min-
ing has become the main economic activity in Kedougou and has
led to increased urbanization, more activity in the forest and mas-
sive immigration of non-immune populations. In association with
these disruptions, a YF outbreak occurred in Kedougou in 2010. In
thispaperwereport epidemiological, virological andentomological
information about this outbreak.
Methods & Materials: An human surveillance of Acute Febrile
illnesses were implemented in 7 clinics in Kedougou region. Also
entomologic andmonkeysurveyswere carriedout in the samearea.
Human andmonkey sampleswere tested for YFV- PCR and IgM and
IgGYFantibodiesbyELISA.Mosquitoeswere sorted inmonospeciﬁc
pools and tested by YFV RT-PCR.
Results: From January 2010 to December 2011 9,213 patients
were enrolled and 13 were conﬁrmed as YF (0.14%), including 12
IgM antibody positives, and 2 PCR positive and 10 probable cases.
Three thousand four hundred and seventy seven (3,477) and 1,793
mosquito pools were respectively collected and tested for YFV by
PCR and virus isolation in 2010 and 2011. YFV was detected in
67 pools of mosquitoes (1.9%). Additionally, 378 monkeys were
screened for anti-YFV IgM and neutralizing antibody; one monkey
sample presented anti-YFV IgM, and seroprevalence of YF neu-
tralizing antibodies among juvenile monkeys increased from 4 to
42% between 2010 and 2011. Entomological investigations dur-
ing the YF outbreak revealed that Ae. aegypti was present in all
localities;Aedes furcifer was the predominant species and Breteau
indexes were well above the epidemic threshold.
Conclusion: Increased urbanization and migration of suscep-
tible populations may favor adaptation of Ae Aegypti to domestic
context and the presence of infected Aedes furcifer that would lead
to intermediate or urban transmission of YFV.
http://dx.doi.org/10.1016/j.ijid.2014.03.878
